ARCHIVES

The NCI director and acting FDA commissioner called for faster approval of cancer drugs in speech to FDA staff.

This article is from The Cancer Letter archive.

Vol. 31 No. 38 | October 21, 2005

Download PDF Visit The Full Archive

Related Articles

Hospital to Review Medenica’s Privileges, With Conditions

November 5, 1993

Human Genome Consortium Completes “Working Draft”.

June 30, 2000

The March: Cancer Centers To Plan Events In Conjunction With Sept. 26 March

April 10, 1998

Believers “Flout Fundamental Law Of Physics,” Park Says.

August 1, 2008

Progress Toward Year 2000 Goal Slow, But NCAB Says It’s Too Early, Only Data Up To ’87 Available

January 12, 1990

FDA examining endpoints for approval of cancer therapies, potential departure from survival as the gold standard, Oncology Division Director Richard Pazdur says in interview.

November 7, 2003